CAMEO+ eventCORPORATE2026-04-09馃嚚馃嚦
Gan & Lee Pharmaceuticals signs exclusive licensing deal with JW Pharmaceutical
source: Gan & Lee Pharmaceuticals -> target: JW Pharmaceutical
On 2026-04-09, Gan & Lee Pharmaceuticals announced an exclusive licensing agreement with JW Pharmaceutical to support clinical development, regulatory filing, and commercialization of Bofanglutide Injection in South Korea. The deal is aimed at advancing the global commercialization of the GLP-1 receptor agonist.
0.17Significance2.0Magnitude0.2Systemic0.3Market1Articles
Location
BeijingBeijingEast AsiaChinaAsia39.904, 116.407
Story Links